PIK3CD and graft versus host disease: To assess the impact of p110δ inactivation on T cells in GvHD, we used transgenic (p110δD910A) knockin mice, which carry a loss-of-function point mutation in the kinase domain of p110δ (Okkenhaug et al., 2002).